Literature DB >> 1731892

Proton NMR studies of [N-MeCys3,N-MeCys7]TANDEM binding to DNA oligonucleotides: sequence-specific binding at the TpA site.

K J Addess1, D E Gilbert, R K Olsen, J Feigon.   

Abstract

[N-MeCys3,N-MeCys7]TANDEM, an undermethylated analogue of Triostin A, contains two N-methyl groups on the cysteine residues only. Footprinting results showed that [N-MeCys3,N-MeCys7]TANDEM binds strongly to DNA rich in A.T residues [Low, C. M. L., Fox, K. R., Olsen, R. K., & Waring, M. J. (1986) Nucleic Acids Res. 14, 2015-2033]. However, it was not known whether specific binding of [N-MeCys3,N-MeCys7]TANDEM requires a TpA step or an ApT step. In 1:1 saturated complexes with the octamers [d(GGATATCC)]2 and [d(GGTTAACC)]2, [N-MeCys3,N-MeCys7]TANDEM binds to each octamer as a bis-intercalator bracketing the TpA step. The octadepsipeptide ring binds in the minor groove of the DNA. Analysis of sugar coupling constants from the phase-sensitive COSY data indicates that the sugar of the thymine in the TpA binding site adopts predominantly an N-type sugar conformation, while the remaining sugars on the DNA adopt an S-type conformation, as has been observed in other Triostin A and echinomycin complexes. The drug does not bind to the octamer [d(GGAATTCC)]2 as a bis-intercalator. Only weak nonintercalative binding is observed to this DNA octamer. These results show unambiguously that [N-MeCys3,N-MeCys7]TANDEM binds sequence specifically at TpA sites in DNA. The factors underlying the sequence specificity of [N-MeCys3,N-MeCys7]TANDEM binding to DNA are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731892     DOI: 10.1021/bi00117a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Proton NMR study of the [d(ACGTATACGT)]2-2echinomycin complex: conformational changes between echinomycin binding sites.

Authors:  D E Gilbert; J Feigon
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

2.  DNA recognition by quinoxaline antibiotics: use of base-modified DNA molecules to investigate determinants of sequence-specific binding of triostin A and TANDEM.

Authors:  C Bailly; M J Waring
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  The effects of sequence context on base dynamics at TpA steps in DNA studied by NMR.

Authors:  K McAteer; P D Ellis; M A Kennedy
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

4.  Site selective bis-intercalation of a homodimeric thiazole orange dye in DNA oligonucleotides.

Authors:  J P Jacobsen; J B Pedersen; L F Hansen; D E Wemmer
Journal:  Nucleic Acids Res       Date:  1995-03-11       Impact factor: 16.971

5.  NMR investigation of Hoogsteen base pairing in quinoxaline antibiotic--DNA complexes: comparison of 2:1 echinomycin, triostin A and [N-MeCys3,N-MeCys7] TANDEM complexes with DNA oligonucleotides.

Authors:  K J Addess; J Feigon
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

6.  Bis-intercalation of a homodimeric thiazole orange dye in DNA in symmetrical pyrimidine-pyrimidine-purine-purine oligonucleotides.

Authors:  L F Hansen; L K Jensen; J P Jacobsen
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

7.  Sequence-specific binding of [N-MeCys3,N-MeCys7]TANDEM to TpA.

Authors:  M Lavesa; R K Olsen; K R Fox
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

8.  Dissociation of the AT-specific bifunctional intercalator [N-MeCys3,N-MeCys7]TANDEM from TpA sites in DNA.

Authors:  M C Fletcher; R K Olsen; K R Fox
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

9.  Role of stacking interactions in the binding sequence preferences of DNA bis-intercalators: insight from thermodynamic integration free energy simulations.

Authors:  Esther Marco; Ana Negri; F Javier Luque; Federico Gago
Journal:  Nucleic Acids Res       Date:  2005-11-10       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.